AI research model for breast cancer screening developed by Google Health licensed for the first time
Google Health has partnered with iCAD, which works in cancer diseases, to develop the artificial intelligence research model for breast cancer screening. So he licensed this system to iCAD. The aim of the partnership is to assist radiologists in breast cancer detection and risk assessment… iCAD, which produces cancer detection and treatment solutions, will use Google’s AI-assisted breast imaging technology in its portfolio.
In 2020, it was announced that an artificial intelligence system developed by Google made more accurate detections according to experts in mammography screening . According to Google’s research published in the journal Nature, it has been revealed that the company’s new artificial intelligence (AI) model can detect breast cancer in mammograms with more accuracy than experts.
Breast cancer is the most common type of cancer and the most common cause of death in women. Research suggests that one out of every eight women will develop breast cancer at some point in her life. At this point, companies producing technology in this field draw attention.
Last October, breast cancer screening platform Vara announced that it had received an investment of 4.5 million Euros . The $4.5 million investment was managed by VI Partners. Med360, AI Venture Studio and Think Health participated in the investment round. The company will use the new investment in its goal of reaching 1 billion women worldwide with breast cancer screening. Founded by Jonas Muff and Stefan Bunk, Vara was launched in 2018. The company uses artificial intelligence technology in breast cancer screening. Vara’s goal is to make breast cancer screening accessible to every woman. Early detection of breast cancer, which is among the deadliest types of cancer.
